The purpose of this study was to identify predictors of adverse cardiovascular events after CABG in patients with previous heart failure by looking at clinical data, standard laboratory and instrumental data, biomarkers (NGAL, GDF-15, NTproBNP, TGF beta 1, hsCRP), and patients’ adherence before CABG. This evidence concerns the gene NPPB and heart failure.